Escitalopram is an antidepressant in a group of drugs called selective serotonin reuptake inhibitors (SSRIs). Escitalopram affects chemicals in the brain that may be unbalanced in people with depression or anxiety.Escitalopram is used to treat anxiety in adults. Escitalopram is also used to treat major depressive disorder in adults and adolescents who are at least 12 years old.
Escitalopram may also be used for purposes not listed in this medication guide.
Almost white to white crystalline powder.
Result
Almost white crystalline powder.
Soluble in methanol.
Result
Soluble in methanol.
The sample spectrum should be in concordant with that of working standard.
Result
Complies
The retention time of the principal peak in the test sample chromatogram should be match with that of the working standard in “Related substances by HPLC” test.
Result
Complies
Not more than 1.0 % w/w.
Result
0.69 % w/w
Not more than 1.0 % w/w.
Result
0.32 % w/w
Not more than 0.10 % w/w.
Result
0.05 % w/w
Not more than 20 ppm.
Result
Below 20 ppm.
98.0 % – 102.0 % w/w
Result
99.1 % w/w
(+)10.0° to (+) 14.0°
Result
99.1 % w/w
Not more than 0.5 %
Result
0.05%
Not more than 1.0 %
Result
0.08%
Note: We are leading channel partner of much API manufacturer, supplier & exporters and Pharmaceutical raw material in Colombo, Chili, Ecuador and Globally.
Product Identifier
Escitalopram Oxalate
MSDS Prepared By
R&D Department
Product Name
Escitalopram Oxalate
Synonym
1 [ (3-Dimethyl amino) –propyl)-1-(4-fluorophenly) -5-isobenzofuran carbonatite oxalate.
Molecular Formula
C20H21FN2O(COH)2
Molecular Weight
414.0
CAS Number
219861-08-2
Emergency Overview
Irritating to eyes, respiratory system and skin.
Potential Health effects
Eyes
Causes eye irritation
Skin
Causes skin irritation. May be harmful, if absorbed through skin.
Ingestion
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation
May cause respiratory tract irritation. May be harmful, if inhaled.
Chronic
N/A
Skin Contact
Wipe off excess material from skin then immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes, Get medical attention immediately. Wash clothing & shoes thoroughly before reuse.
Eye Contact
Immediately flush eyes with plenty of water for at least 15 minutes lifting lower and upper eyelids occasionally. Get medical attention immediately.
Inhalation
Remove to fresh air. Get medical attention immediately.
Ingestion
If swallowed, INDUCE VOMITING. Give large quantities of water. Never give anything by mouth to an unconscious person. Get medical attention immediately.
General Information
As in any fire, wear a self-contained breathing apparatus in pressure-demand, and full protective wear.
Extinguishing Media
Use water spray, dry chemical, carbon dioxide or chemical foam.
General Information
Use proper protective equipment as indicated in section-8.
Spills / Leaks
Ventilate area of spill. Isolate hazard area. Keep away unnecessary and unprotected personal from entering. Flush with water. Use wet mop and vacuum to pick up spilled product. Dispose the collected powder and washings as per local laws.
Handling
Avoid breathing powder, vapor, mist., or gas. Avoid contact with skin & eyes.
Storage
Store in well closed containers.
Engineering Controls
Facilities storing or utilizing this material should be equipped with an eye was facility and a safety shower. Use adequate ventilations to keep airborne concentrations low.
Personnel Protective Equipment
Eyes
Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA`s eye and face protection regulations.
Skin
Wear appropriate protective gloves to prevent skin exposure.
Clothing
Wear appropriate protective clothing to prevent skin exposure.
Physical State
Powder
Color
Almost white to white
Odor
N/A
pH
N/A
Viscosity
N/A
Boiling Point
N/A
Auto ignition temperature
N/A
Flash Point
N/A
Explosion Limit, Lower
N/A
Explosion Limit, Higher
N/A
Decomposition temperature
N/A
Solubility in Water
N/A
Freezing / Melting Point
N/A
Specific Gravity / Density
N/A
Vapor Density
N/A
Vapor Pressure
N/A
Assay
98%(+)
Chemical Stability
Stable at Room temperature in closed containers under normal storage and humidity conditions.
Conditions to avoid
Incompatible materials
Incompatibility with others
Strong oxidizing agents
Hazardous decomposition products
Hydrogen bromide, Nitrogen oxides, Carbon monoxide
Hazardous polymerization
Has not been reported
Oral Rat : LD50
800mg/kg
To the best of our knowledge the toxicological properties have not been thoroughly investigated. However, harmful if swallowed in large amount., causes irritation if it contacts with eyes
Data Not Available.
Waste Disposal
Whatever cannot be saved for recovery or recycling should be managed in an appropriate and approved waste disposal facility. Processing, use or contamination of this product may change the waste management options. Dispose off container and unused contents in accordance with federal, state and local requirements
IATA Non-hazardous for transport.
European / international regulations
European labeling in accordance with EC Directives
Risk phrases
Irritating to eyes, respiratory systems and skin.
Risk
Irritating to eyes, respiratory systems and skin.
Safety phrases
In case of contact with eyes, rinse immediately with plenty of water & seek medical advice.
Global Pharma provides information contained herein in good faith but makes no representation as to its comprehensives or accuracy. This document is intended only as a guide to the appropriate precautionary handling of the material by a properly trained person using this product.
Individuals receiving the information must exercise their independent judgment in determining its appropriateness for a particular purpose.
GLOBAL PHARMA MAKES NO REPRESENTATIONS OR WARRANTIES, EITHER EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY WARRANTIES OR MERCHANTABILITY, FITNESS FOR A PARTICULER PURPOSE WITH RESPECT TO THE INFORMATION SET FORTH HEREIN OR THE PRODUCT WHICH THE INFORMATION REEFERS. GLOBAL PHARMA WILL NOT BE RESPONSIBLE FOR DAMAGES RESULTING FROM USE OF RELIANCE UPON THIS INFORMATION.